Your browser doesn't support javascript.
loading
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.
Zhang, Hengwei; Liesveld, Jane L; Calvi, Laura M; Lipe, Brea C; Xing, Lianping; Becker, Michael W; Schwarz, Edward M; Yeh, Shu-Chi A.
Affiliation
  • Zhang H; Center for Musculoskeletal Research, University of Rochester Medical Center, 601 Elmwood Ave, Box 665, Rochester, NY, 14642, USA. Hengwei_Zhang@URMC.Rochester.edu.
  • Liesveld JL; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. Hengwei_Zhang@URMC.Rochester.edu.
  • Calvi LM; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.
  • Lipe BC; Department of Medicine, Division of Hematology/Oncology and Bone Marrow Transplantation Program, University of Rochester Medical Center, Rochester, NY, USA.
  • Xing L; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.
  • Becker MW; Department of Medicine, Division of Endocrinology/Metabolism, University of Rochester Medical Center, Rochester, NY, USA.
  • Schwarz EM; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.
  • Yeh SA; Department of Medicine, Division of Hematology/Oncology and Bone Marrow Transplantation Program, University of Rochester Medical Center, Rochester, NY, USA.
Bone Res ; 11(1): 15, 2023 Mar 14.
Article in En | MEDLINE | ID: mdl-36918531
Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone remodeling likely imposes additional heterogeneity within the BMME to yield differential clonal responses. A holistic understanding of the role of bone remodeling in regulating the stem cell niche and how these interactions are altered in age-related hematological malignancies will be critical to the development of novel interventions. To advance this understanding, herein, we provide a synopsis of the cellular and molecular constituents that participate in bone turnover and their known connections to the hematopoietic compartment. Specifically, we elaborate on the coupling between bone remodeling and the BMME in homeostasis and age-related hematological malignancies and after treatment with bone-targeting approaches. We then discuss unresolved questions and ambiguities that remain in the field.

Full text: 1 Database: MEDLINE Language: En Journal: Bone Res Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: Bone Res Year: 2023 Type: Article Affiliation country: United States